- Methyl salicylate 105mg / Levomenthol 31.5mg medicated plasters
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Methyl salicylate 105mg / Levomenthol 31.5mg medicated plasters | Start Date 12-03-2019 | End Date |
Abbreviated Name | Abbreviated Name Methyl salicylate 105mg/Levomenthol 31.5mg | Start Date 12-03-2019 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- plaster
- Unit Dose UOM
- plaster
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Medicated plaster
- Ontology Form/Route
- medicatedplaster.cutaneous
- Name Basis
- Other
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 10030200
Code | Start Date | End Date |
---|---|---|
36866211000001105 | 12-03-2019 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Levomenthol | Based on Ingredient Substance | 31.5 mg | ||
Methyl salicylate | Based on Ingredient Substance | 105 mg |
Name
Methyl salicylate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
105
Strength and UOM (Dmr)
Name
Levomenthol
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
31.5
Strength and UOM (Dmr)
Parent Products
-
VTMMethyl salicylate + Levomenthol
-
VMP(Current) Methyl salicylate 105mg / Levomentho...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
3 plaster | 299 | Part VIIIA Category C |
5 plaster | 419 | Part VIIIA Category C |